typically produces a subclass of ergot alkaloids not derived from agroclavine or lysergic acid.
synthesized by several species of fungi. Historically, ergot alkaloids caused periodic mass 34 poisonings due to infection of grain crops by the ergot fungus Claviceps purpurea (1).
35
Agriculturally, ergot alkaloids in forage grasses colonized by endophytic Epichloë spp.
36
[including many fungi recently realigned from genus Neotyphodium (2)] reduce weight gain and 37 fitness in grazing animals (3, 4) . Clinically, the structural similarities of ergot alkaloids to 
43
Representatives of two major families of fungi-the Clavicipitaceae and the
44
Trichocomaceae-produce ergot alkaloids. All ergot alkaloids-producing fungi share early 45 pathway steps before diverging to produce lineage-specific classes of ergot alkaloids (Fig. 1 ).
46
Members of the Clavicipitaceae, including Claviceps purpurea or the endophytic Epichloë 47 species such as E. festucae var. lolii × E. typhina isolate Lp1 (2, 9) (henceforth called E. sp.
48
Lp1), synthesize lysergic acid-based alkaloids in which the D ring of the ergoline nucleus is 49 unsaturated between carbons 9 and 10, and carbon 17 is highly oxidized (Fig. 1) (4, 10, 11 Schiff base formation (14-16). The resulting iminium ion is subsequently reduced by EasG to 57 form festuclavine (16, 17) , which may be modified at carbons 9 and/or 2 to form various 58 fumigaclavine derivatives (Fig. 1) . Most ergot alkaloid-producing fungi in the Clavicipitaceae,
59
however, synthesize the 8,9 unsaturated clavine agroclavine from chanoclavine aldehyde via the 60 activity of an alternate version of EasA that acts as an isomerase rather than a reductase (15, 17) .
61
In C. purpurea and Epichloë spp., agroclavine is oxidized to form elymoclavine, and 62 elymoclavine is further oxidized and isomerized to form lysergic acid (Fig. 1 ). Lysergic acid is 63 then incorporated into ergopeptines and/or lysergic acid amides. Lysergic acid derivatives are the 64 ergot alkaloids used for pharmaceutical development, but these compounds are produced 65 exclusively in clavicipitaceous fungi and not in model organisms that would facilitate their 66 modification and development.
67
The genetics of many steps in the ergot alkaloid pathway has been characterized; 68 however, the identity of the gene encoding the oxidase that converts agroclavine to elymoclavine 69 has remained elusive. All known genes involved in ergot alkaloid synthesis (eas genes) in both
70
A. fumigatus and the Clavicipitaceae have been found in clusters (Fig. 2) (11, (18) (19) (20) (21) (22) (23) (24) application of the PCR protocol described above for easA but with primer combination 2. Coding 109 sequences and 3′ untranslated region of easH were amplified from E. sp. Lp1 DNA with the 110 same PCR protocol as easA; however, the easH reaction was primed with primer combination 3.
111
After each PCR, the products were cleaned with QIAquick columns (Qiagen, Gaithersburg, 
126
The integrity of the construct was verified by DNA sequencing.
127
Fungal transformation. Candidate oxidase constructs were co-transformed into A. introduced with a particular construct (Fig. 3) . Further evidence of successful expression of the (Table 2 ). In addition, the easA/cloA-expressing strains 11 accumulated a pair of polar compounds that co-eluted with lysergic acid/isolysergic acid 215 standards (Fig. 4) . The identity of the compounds as lysergic acid and its diastereoisomer was 216 supported by LC/MS analyses in which the easA/cloA strains produced parent ion and fragments 217 consistent with those arising from the lysergic acid standard (Fig. 5) . These data indicate that
218
CloA catalyzes a cumulative six electron oxidation of agroclavine to lysergic acid and that CloA 
223
In addition to known ergot alkaloids described above, strains transformed with constructs and B (Table 3 ). These data demonstrate a dependency on agroclavine for synthesis of the by Haarmann et al. (26) . Our data also suggest that CloA or the co-expressed EasA catalyzes the 266 double bond isomerization, from position 8,9 to 9,10.
267
The lack of detectable elymoclavine, or any other intermediates in the oxidation series The recent discovery of 2-reverse prenylated versions of festuclavine and fumigaclavine B in A. 
